Search research articles
Contact Us
Filters
Showing results (61-70 of 202) with videos related to
Page
of 21
Sort By:
Amino Acids
|
November 6, 2013
The structural features of effective antagonists of the luteinizing hormone releasing hormone
A Janecka, T Janecki, C Bowers, et al.
Molecular Aspects of Medicine
|
January 1, 1994
Treatment of essential hypertension with coenzyme Q10
P Langsjoen, P Langsjoen, R Willis, et al.
The Clinical Investigator
|
January 1, 1993
Myocardial preservation by therapy with coenzyme Q10 during heart surgery
W V Judy, W W Stogsdill, K Folkers
Research Communications in Chemical Pathology and Pharmacology
|
September 1, 1978
Potentiation of the toxicity of adriamycin by propranolol
J Y Choe, A B Combs, K Folkers
Experientia
|
April 15, 1984
Long-term administration of a substance P antagonist, (D-Pro2, D-Trp7,9)-SP, abolishes the response to ocular trauma
G Bynke, R Håkanson, J Hörig, et al.
Amino Acids
|
November 6, 2013
Effective antagonists of luteinizing hormone releasing hormone modified at position one
A Janecka, T Janecki, C Bowers, et al.
Research Communications in Chemical Pathology and Pharmacology
|
June 1, 1975
Study of periodontal disease and coenzyme Q
Y Iwamoto, R Nakamura, K Folkers, et al.
International Journal of Peptide and Protein Research
|
July 1, 1994
New, highly active antagonists of LHRH with acylated lysine and p-aminophenylalanine in positions 5 and 6
A Janecka, T Janecki, C Y Bowers, et al.
International Journal of Tissue Reactions
|
January 1, 1990
Coenzyme Q10: clinical benefits with biochemical correlates suggesting a scientific breakthrough in the management of chronic heart failure
S A Mortensen, S Vadhanavikit, K Muratsu, et al.
Drugs Under Experimental and Clinical Research
|
January 1, 1985
Long-term coenzyme Q10 therapy: a major advance in the management of resistant myocardial failure
S A Mortensen, S Vadhanavikit, U Baandrup, et al.
Page
of 21
Search research articles
Search
Showing results (61-70 of 202) with videos related to
Sort By:
Page
of 21
Amino Acids
|
November 6, 2013
The structural features of effective antagonists of the luteinizing hormone releasing hormone
A Janecka, T Janecki, C Bowers, et al.
Molecular Aspects of Medicine
|
January 1, 1994
Treatment of essential hypertension with coenzyme Q10
P Langsjoen, P Langsjoen, R Willis, et al.
The Clinical Investigator
|
January 1, 1993
Myocardial preservation by therapy with coenzyme Q10 during heart surgery
W V Judy, W W Stogsdill, K Folkers
Research Communications in Chemical Pathology and Pharmacology
|
September 1, 1978
Potentiation of the toxicity of adriamycin by propranolol
J Y Choe, A B Combs, K Folkers
Experientia
|
April 15, 1984
Long-term administration of a substance P antagonist, (D-Pro2, D-Trp7,9)-SP, abolishes the response to ocular trauma
G Bynke, R Håkanson, J Hörig, et al.
Amino Acids
|
November 6, 2013
Effective antagonists of luteinizing hormone releasing hormone modified at position one
A Janecka, T Janecki, C Bowers, et al.
Research Communications in Chemical Pathology and Pharmacology
|
June 1, 1975
Study of periodontal disease and coenzyme Q
Y Iwamoto, R Nakamura, K Folkers, et al.
International Journal of Peptide and Protein Research
|
July 1, 1994
New, highly active antagonists of LHRH with acylated lysine and p-aminophenylalanine in positions 5 and 6
A Janecka, T Janecki, C Y Bowers, et al.
International Journal of Tissue Reactions
|
January 1, 1990
Coenzyme Q10: clinical benefits with biochemical correlates suggesting a scientific breakthrough in the management of chronic heart failure
S A Mortensen, S Vadhanavikit, K Muratsu, et al.
Drugs Under Experimental and Clinical Research
|
January 1, 1985
Long-term coenzyme Q10 therapy: a major advance in the management of resistant myocardial failure
S A Mortensen, S Vadhanavikit, U Baandrup, et al.
Page
of 21